Evidence map›Paper›PMID 41123996›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Intracellular pH regulates ubiquitin-mediated degradation of the MAP kinase ERK3.

Chloé Tesnière, Fadia Boudghene-Stambouli, Marc Severin, Mallorie Poët, Laure Voisin, Muthulakshmi Ponniah, Mirela Pascariu, Eric Bonneil, Jean-François Trempe, Pierre Thibault and 3 more

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chloé Tesnière *Institute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.ORCID 0009-0006-2386-4620
Fadia Boudghene-Stambouli *Institute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.ORCID 0009-0008-2695-0764
Marc SeverinSection for Cell Biology and Physiology, Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen DK-2200, Denmark.ORCID 0000-0003-4293-8059
Mallorie PoëtCNRS, Laboratoire de Physiomédecine Moléculaire, Université Côte d'Azur, Nice 06107, France.ORCID 0000-0002-6969-2485
Laure VoisinInstitute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.ORCID 0009-0003-7091-2793
Muthulakshmi PonniahSection for Cell Biology and Physiology, Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen DK-2200, Denmark.
Mirela PascariuInstitute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.ORCID 0009-0006-8751-2587
Eric BonneilInstitute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.
Jean-François TrempeDepartment of Pharmacology and Therapeutics, McGill University, Montreal, QC H3G 1Y6, Canada.ORCID 0000-0002-6543-3371
Pierre ThibaultInstitute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.
Laurent CounillonCNRS, Laboratoire de Physiomédecine Moléculaire, Université Côte d'Azur, Nice 06107, France.ORCID 0000-0001-7711-8830
Stine Falsig PedersenSection for Cell Biology and Physiology, Department of Biology, Faculty of Science, University of Copenhagen, Copenhagen DK-2200, Denmark.ORCID 0000-0002-3044-7714
Sylvain MelocheInstitute for Research in Immunology and Cancer, Montreal, QC H3T 1J4, Canada.ORCID 0000-0002-6201-7786

Funding

Canadian Government | Canadian Institutes of Health Research (CIHR) PJT-152911Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) 03684Canadian Government | Natural Sciences and Engineering Research Council of Canada (NSERC) 311598Cancer Research Society (CRS) 25388Carlsbergfondet (Carlsberg Foundation) CF20-0491 CF23-1744Genome Canada (GC) NAIndependent Research Fund Denmark 0135-00139B
6 · The paper itself

Abstract

Intracellular pH (pHi) influences diverse cellular processes, including cell proliferation, metabolism, and migration, and is linked to metabolic diseases and cancer. Protonation alters protein charge and conformation, modulating different aspects of protein function. How pHi fluctuations are sensed by signaling proteins and translated into cellular responses remains incompletely understood. Here, we reveal that pHi plays a key role in regulating the stability of the mitogen-activated protein kinase Extracellular signal-regulated kinase 3 (ERK3). Intracellular acidification markedly increases the half-life of ERK3, whereas alkalinization accelerates its degradation. The pH-dependent regulation of ERK3 is rapid, reversible, and consistent across cell types. Mechanistically, we identified a region in the C-terminus of ERK3 that contains pH-sensing motifs. We further show by quantitative proteomics that short-term acidification or alkalinization globally affects the cellular proteome. Our findings underscore the critical role of pHi in ERK3 turnover and suggest a broader role for pH in regulating protein stability and cell signaling.

Indexed as

Mitogen-Activated Protein Kinase 6UbiquitinHEK293 CellsHumansHydrogen-Ion ConcentrationMitogen-Activated Protein Kinase 3ProteolysisProteomicsSignal TransductionMAPK3 protein, humanMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase 6UbiquitinERK3intracellular pHMAP kinasesproteomics

Identifiers

PMID41123996
PMCPMC12582255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.